Meta-analysis of the risk of venous thrombosis in individuals with antiphospholipid antibodies without underlying autoimmune disease or previous thrombosis

Lupus - Tập 7 Số 1 - Trang 15-22 - 1998
Denis Wahl1, F. Guillemin2, Emmanuel de Maistre3, Claude Jeandel1, Thomas Lecompte3, G Thibaut1
1Service de Medecine H. Nancy University Hospital, Nancy, France
2Ecole de santé publique, Faculté de Medicine, Vandoeuvre-les-Nancy, Nancy, France
3Laboratoire d'hémostase, Nancy University Hospital, Nancy, France

Tóm tắt

Patients with systemic lupus erythematosus (SLE) and antiphospholipid antibodies (aPL) are at a greater risk for venous thromboembolism (VTE) than SLE patients without these antibodies. For patients without SLE there is a controversy about the risk associated with these antibodies and about their prognostic significance. We reviewed the degree of evidence and describe the odds ratio for VTE associated with aPL, namely the lupus anticoagulant (LA) and anticardiolipin antibodies (aCL), in patients without SLE. The study was a meta-analysis of seven observational studies of risk for antiphospholipid associated venous thromboembolism (VTE), excluding SLE patients. The strategies to identify published research included a computerized literature search and the review of citations in primarily relevant articles for the period 1983 to 1997. A summary of study characteristics and a critical appraisal of study quality were done. Summary odds ratios were obtained conducted using a random and a fixed effects-model. The overall odds ratio for aCL associated VTE obtained by fixed-effects model was 1.56 (95% CI, 1.10—2.24) and 1.64 (95% CI, 0.93—2.89) by random-effects model. The heterogeneity of these results appeared to be due in part to the detection limit of the aCL assay: the odds ratio was 3.21 (95% CI, 1.11—9.28) with both models when high titres only were considered. The overall odds ratio for LA associated VTE was 11.1 (95% CI, 3.81—32.3). In conclusion meta-analysis of the risk for antiphospholipid associated thrombosis demonstrated a higher risk in patients with the LA than in other patients. This risk was also higher than in patients with aCL even when high titres only were considered.

Từ khóa


Tài liệu tham khảo

10.1016/0140-6736(93)91477-4

10.1093/rheumatology/34.6.493

10.1177/096120339600500501

10.1097/00005792-198911000-00004

10.1136/ard.52.9.689

10.1056/NEJM199504133321504

10.7326/0003-4819-117-4-303

10.1055/s-0038-1650686

10.1006/clin.1996.0089

10.1177/096120339700600510

10.7326/0003-4819-117-12-997

10.1182/blood.V86.10.3685.bloodjournal86103685

10.1177/096120339700600508

10.1177/096120339600500602

10.1378/chest.108.4_Supplement.227S

10.7326/0003-4819-115-10-787

10.1182/blood.V68.4.869.869

10.1055/s-0038-1648143

10.1177/096120339400300415

Loizou S, 1986, Clin Exp Immunol, 62, 738

Harris EN, 1987, Clin Exp Immunol, 68, 215

10.1093/ajcp/94.4.476

10.1093/ajcp/101.5.616

Gardner MJ, 1992, Microcomputer program manual

10.1016/0197-2456(86)90046-2

10.1093/oxfordjournals.epirev.a036298

Breslow NE, 1980, The Analysis of Case-Control Studies

Gahlinger PM, 1995, Computer Programs for Epidemiologic Analysis. PEPI Version 2. Stone Mountain

10.1055/s-0038-1650551

10.1055/s-0038-1648530

Fijnheer R, 1994, Lupus, 3, 361

Simioni P, 1994, Lupus, 3, 361

10.1055/s-0038-1653795

10.1177/096120339600500504

10.1016/0140-6736(90)91374-J

10.1056/NEJM199509073331016

Thông tin
Thông tin xuất bản

Lupus

Tập 7 Số 1

15-22

Thông tin tác giả